Autor: |
Shumakov DV; Moscow Regional Research and Clinical Institute named after M. F. Vladimirsky (MONIKI)., Dontsov VV; Moscow Regional Research and Clinical Institute named after M. F. Vladimirsky (MONIKI)., Zybin DI; Moscow Regional Research and Clinical Institute named after M. F. Vladimirsky (MONIKI). |
Jazyk: |
ruština |
Zdroj: |
Kardiologiia [Kardiologiia] 2019 Sep 11; Vol. 59 (9S), pp. 16-24. Date of Electronic Publication: 2019 Sep 11. |
DOI: |
10.18087/cardio.n460 |
Abstrakt: |
Left ventricular hypertrophy - is one of the most frequent structural changes in the heart. This article is devoted to the assessment of modern views on the causes of myocardial hypertrophy of the donor heart, indications and contraindications for the heart trans‑ plantation, the outlook of expanding the pool of effective donors through the use of these hearts. Here are considered the issues of post-transplantation remodeling of the donor heart myocardium, The pathogenesis features, the nascence risk and possibilities of drug regulation of the transplanted heart's myocardial hypertrophy of the left ventricle. |
Databáze: |
MEDLINE |
Externí odkaz: |
|